Prognostic Models With Competing Risks
2009 · Epidemiology · 629 citations
https://doi.org/10.1097/ede.0b013e3181a39056
M
Marcel Wolbers
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
178
Papers
12.5K
Citations
59
h-index
120
i10-index
Marcel Wolbers is an academic researcher from Roche (Switzerland). The author has contributed to research in topics: Mosquito-borne diseases and control & Infectious Diseases and Tuberculosis & Statistical Methods in Clinical Trials. The author has an h-index of 59, co-authored 152 publications.
ORCID: 0000-0003-4915-9015Papers by this author
worksProcalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial
2007 · BMC Health Services Research · 130 citations
https://doi.org/10.1186/1472-6963-7-102
Clinical evaluation of dengue and identification of risk factors for severe disease: protocol for a multicentre study in 8 countries
2016 · BMC Infectious Diseases · 74 citations
https://doi.org/10.1186/s12879-016-1440-3
Intensified treatment with high dose Rifampicin and Levofloxacin compared to standard treatment for adult patients with Tuberculous Meningitis (TBM-IT): protocol for a randomized controlled trial
2011 · Trials · 68 citations
https://doi.org/10.1186/1745-6215-12-25
Clinical presentations, diagnosis, mortality and prognostic markers of tuberculous meningitis in Vietnamese children: a prospective descriptive study
2016 · BMC Infectious Diseases · 64 citations
https://doi.org/10.1186/s12879-016-1923-2
Gatifloxacin versus ceftriaxone for uncomplicated enteric fever in Nepal: an open-label, two-centre, randomised controlled trial
2016 · The Lancet Infectious Diseases · 63 citations
https://doi.org/10.1016/s1473-3099(15)00530-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat